webinar register page

Webinar banner
Advancing T cell Therapies Using B-hCD3 Mouse Models
● Current challenges in screening leads and evaluating antibody candidates developed for T cell-mediated immunotherapy
● Generation and validation data for our humanized B-hCD3E and B-hCD3EDG mice
● The preservation of normal immune cell profiles and T cell activation in these models
● The In vivo efficacy of anti-CD3 therapeutics using MC38 tumor models in our CD3-humanized mice

Oct 28, 2021 01:00 PM in Eastern Time (US and Canada)

Webinar logo
* Required information